Lithium-induced Sinus Node Dysfunction: A Case Report

10.4103/TPSY.TPSY_5_20

Ching-Fang Chang；Ying-Chih Cheng；Chun-Tse Chen；Wen-Yin Chen

台灣精神醫學

34卷1期（2020 / 03 / 01）

51 - 52

英文

1. Brunton, LL(ed.),Hilal-Dandan, R(ed.),Knollmann, BC(ed.)(2017).Goodman and Gilman’s the Pharmacological Basis of Therapeutics.New York City:McGraw-Hill Education.
2. George, AL, Jr(2005).Inherited disorders of voltage-gated sodium channels.J Clin Invest,115,1990-1999.
3. Nakamura, M,Nakatsu, K,Nagamine, T(2015).Sinus node dysfunction after acute lithium treatment at therapeutic levels.Innov Clin Neurosci,12,18-20.
4. Naranjo, CA,Busto, U,Sellers, EM(1981).A method for estimating the probability of adverse drug reactions.Clin Pharmacol Ther,30,239-245.
5. Oudit, GY,Korley, V,Backx, PH(2007).Lithium-induced sinus node disease at therapeutic concentrations: linking lithium-induced blockade of sodium channels to impaired pacemaker activity.Can J Cardiol,23,229-232.
6. Shetty, RK,Vivek, G,Parida, A(2013).Lithium-induced sinus node dysfunction at therapeutic levels.BMJ Case Rep,2013,pii: bcr2012008107.
7. Singh, LK,Praharaj, SK,Munda, SK(2011).Lithium-induced sinus node dysfunction at therapeutic serum levels.Natl Med J India,24,151-152.